Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,082,620
  • Shares Outstanding, K 80,288
  • Annual Sales, $ 806,780 K
  • Annual Income, $ -363,300 K
  • EBIT $ 953 M
  • EBITDA $ 1,177 M
  • 60-Month Beta 0.47
  • Price/Sales 7.81
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 52.80% (+0.01%)
  • Historical Volatility 37.98%
  • IV Percentile 37%
  • IV Rank 16.69%
  • IV High 128.79% on 04/24/25
  • IV Low 37.57% on 06/20/25
  • Expected Move (DTE 14) 6.29 (8.08%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 90
  • Volume Avg (30-Day) 292
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 13,283
  • Open Int (30-Day) 11,889
  • Expected Range 71.56 to 84.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.95
  • Number of Estimates 7
  • High Estimate -0.31
  • Low Estimate -1.58
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -295.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.67 +15.04%
on 11/05/25
87.50 -11.03%
on 11/26/25
+10.13 (+14.96%)
since 11/04/25
3-Month
56.51 +37.78%
on 09/08/25
87.50 -11.03%
on 11/26/25
+19.84 (+34.20%)
since 09/04/25
52-Week
35.95 +116.55%
on 05/06/25
87.50 -11.03%
on 11/26/25
+27.99 (+56.14%)
since 12/04/24

Most Recent Stories

More News
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J. , Dec. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 24, 2025 , the company approved non-statutory stock options to purchase an aggregate...

PTCT : 77.85 (+2.76%)
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors

PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation...

PTCT : 77.85 (+2.76%)
CVKD : 11.10 (+25.28%)
Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600

NEW YORK , Nov. 24, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: 

PTCT : 77.85 (+2.76%)
IPG : 24.57 (-1.96%)
SNDK : 213.31 (+9.74%)
OMC : 70.17 (-1.17%)
UPWK : 19.58 (-0.76%)
SPGI : 496.99 (-0.58%)
PINC : 28.26 (+0.32%)
GIL : 58.33 (+1.62%)
FIBK : 33.67 (+1.02%)
HBI : 6.65 (+2.78%)
GIL.TO : 81.47 (+1.71%)
PTC Therapeutics to Host R&D Day

Event to take place on Dec. 2, 2025 in New York City

PTCT : 77.85 (+2.76%)
PTC Therapeutics: Q3 Earnings Snapshot

PTC Therapeutics: Q3 Earnings Snapshot

PTCT : 77.85 (+2.76%)
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

– Initiated US and EU launch of Sephience ™ (sepiapterin) – 

PTCT : 77.85 (+2.76%)
PTC Therapeutics to Participate at Upcoming Investor Conferences

WARREN, N.J. , Oct. 31, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

PTCT : 77.85 (+2.76%)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J. , Oct. 27, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 23, 2025, the company approved non-statutory stock options to purchase an aggregate...

PTCT : 77.85 (+2.76%)
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results

WARREN, N.J. , Oct. 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2025 financial...

PTCT : 77.85 (+2.76%)
PTC Therapeutics (PTCT) Receives a Buy from RBC Capital

In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on PTC Therapeutics, with a price target of $70.00. The company’s shares opened today at $64.60.Elevate Your Investing...

PTCT : 77.85 (+2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 83.84
2nd Resistance Point 81.44
1st Resistance Point 79.64
Last Price 77.85
1st Support Level 75.44
2nd Support Level 73.04
3rd Support Level 71.24

See More

52-Week High 87.50
Last Price 77.85
Fibonacci 61.8% 67.81
Fibonacci 50% 61.72
Fibonacci 38.2% 55.64
52-Week Low 35.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar